A number of cellular pathways are regulated through the reversible phosphorylation of proteins orchestrated by kinases and phosphatases, a central mechanism in the regulation of signal transduction (1). Protein phosphatases can be classified into four gene families each with distinct functions in cells: (i) Serine/threonine phospho-protein phosphatase (PPP); (ii) Mg^2＋-dependent protein phosphatase (PPM/PP2C); (iii) Phospho-tyrosine phosphatase (PTP); (iv) Asp-based protein phosphatase (1-4). PPPs are the most highly conserved phosphatases in eukaryotes, and more than 80% phosphatase activity is contributed to this family. PPPs are further divided into seven subgroups (PP1, PP2A, PP2B, PP4, PP5, PP6, and PP7) based on sequence, structure, and biochemical properties. Approximately 40 catalytic subunits derived from PPPs and PPM/PP2C are responsible for dephosphorylating the majority of Ser/Thr phosphoresidues on proteins, whereas more than 400 kinases are in charge of phosphorylation of Ser/Thr residues. This implies that these phosphatases should be highly regulated, and the majority of catalytic activities is usually attributed to a wide variety of regulatory subunits, forming functionally unique complexes with a limited number of catalytic subunits (Fig. 1) (1-3).

Protein phosphatase 4 (PP4) complex is comprised of one catalytic subunit (PP4C) and five regulatory subunits (PP4R1, PP4R2, PP4R3α, PP4R3β, and PP4R4), typically forming the functional heterodimer (PP4C/PP4R1 or PP4C/PP4R4) or heterotrimer (PP4C/PP4R2/PP4R3α or PP4C/PP4R2/PP4R3β) in cells (Fig. 2) (3-10). PP4C, a catalytic subunit of PP4, was the first identified in 1993 as PPX (designated as PPP4 in human genome nomenclature) and indicated 65% identical to PP2ACα and PP2ACβ. Given the < 70% identity to other phosphatases including PP1, PP2A and PP2B, PP4C cannot be considered as isoforms of these proteins (4). Also, it did not show physical interaction with other phosphatases tested and had the distinct functions (1, 4). The regulatory subunits of PP4 are highly conserved across mammals, yeast and plants. The heterotrimer complex, PP4C-PP4R2-PP4R3 (PPH3-YBL1046W-PSY2), sharing a high homology between human and S. cerevisiae, functions in DNA damage response (DDR) in the both organisms (9,11-13). Arabidopsis also contains regulatory subunits of PP4, PP4R2 domain (putative homologue of PP4R2 in human), and SMEK-1 domain (homologue of PP4R3 in human), even though their functional properties are largely undiscovered. In the beginning, the main effort of PP4 research was focused on the DDR, thus finding that phosphatase directly dephosphorylates many essential proteins particularly in DDR, facilitating efficient DNA repair and check point control: RPA2 (replication protein A2), KAP-1 (KRAB-associated protein-1), γ-H2AX (gamma H2A histone family member X), 53BP1 (p53 binding protein 1), DBC1 (deleted in breast cancer-1) and Rad53 (5-9,14). However, the results of more than a decade of studies in various fields of cell physiology showed that PP4 had many other essential physiological activities as well as DDR: genomic stability (cancer, cell cycle control, and DNA repair), immune response, glucose homeostasis, and neuron development.

In this review, we will summarize the recent understanding and the biological significance of the roles of PP4 in a wide range of cellular physiology including genomic stability, immune response, glucose homeostasis, neuronal development, and plant physiology (Fig. 3).

Genomic stability

Genome is consistently exposed to DNA damages caused by endogenous or exogenous events. If genomic aberration occurs, cells will suffer from disasters such as cell death and transformation. Thus, it is necessary to maintain genomic integrity.

Cancer: It has been known that PP4 is overexpressed in human breast and lung tumors, stage II pancreatic ductal adenocarcinoma, colorectal carcinoma, and glioma (15-18), and also significantly increases JNK-1 (c-Jun N-terminal kinase 1) activity in prostate cancer cell lines, PC-3 and LNCaP, which is essential for proliferation and drug resistance (19), suggesting that PP4 could have oncogenic activity. However, in conflicting studies, PP4R2 gene is deleted in patients with acute myeloid leukemia (AML), required for proper DNA repair and functions as tumor suppressor protein (20). And PP4 recovers the expression of HPK1 (hematopoietic progenitor kinase 1), lost in more than 95% of pancreatic cancer through proteasome-mediated degradation, thus inhibiting cell proliferation of pancreatic cancer cells (21). Paradoxically, PP4 is reported to improve cell proliferation and block apoptosis through downregulation of DR4 (death receptor 4) and dephosphorylation of DBC1, leading to SIRT1 (NAD-dependent deacetylase sirtuin-1) derepression and, subsequently, blocking p53-dependent apoptosis (7, 18, 22, 23) in one respect, but in the other respect, it could impair proliferation and cause apoptosis by inducing low phosphorylation level of PEA-15 (phosphoprotein enriched in astrocytes of 15 kDa) and Bad (Bcl2 associated agonist of cell death) (24, 25). Thus, further studies are required to understand the discrepancy in PP4 functions regarding tumor formation.

Cell cycle: For successful cell division, many processes should occur properly, such as microtubule organization and chromosome segregation. In various species, including human, PP4 has critical functions in microtubule organization (26-30). Caenorhabditis elegans has two pp4 catalytic subunit genes, pph-4.1 and pph-4.2, and PPH-4.1, not PPH-4.2, is necessary for the activation of microtubule nucleation (27). PPH-4.1 interacts with and activates MEI-1 (meiotic spindle formation protein 1), which must be inactivated via ubiquitin-dependent degradation after the meiosis to allow for the formation of the mitotic spindle, and also promotes the activity of PPFR-1 (homologue of PP4R1 in C. elegans), which regulates MEI-1 during mitosis (28). Also, abnormal phosphorylation of NDEL1 (nuclear distribution protein nudE-like 1) and uncontrolled activation of Cdk1 (cyclin-dependent kinase 1) by PP4C disruption induce excessive recruitment of Katanin p60 to the centrosome and consequently, cause microtubule defects (29). Also, it was reported that PP4C depletion leads aberrant regulation of α-tubulin, γ-tubulin, PLK-1 (polo-like kinase 1), and Aurora A, and precludes the organization of actin cytoskeleton, possibly by inactivated Rho GTPases, Rac1 (Ras-related C3 botulinum toxin substrate 1) and Cdc42 (cell division control protein 42), thus impairing centrosome maturation and cell migration (31). In addition, PP4C interacts with γ-tubulin and TUBGCP2 (tubulin gamma complex associated protein 2) and dephosphorylates γ-tubulin (30). When the cells are arrested in mitosis with spindle toxins such as nocodazole or paclitaxel, PP4 activity is inhibited through phosphorylation of its regulatory subunit PP4R2 and PP4R3α, thus leading the blockage of microtubule nucleation by γ-tubulin. Kinetochore assembly is also required for PP4-CENP-C (centromeric protein C) interaction in Drosophila (32). Additionally, PP4 is related to chromosome pairing and crossover formation (33). Pph3D mutants have defects in crossover repair and centromere pairing, with upregulated phosphorylation of Zip1 (34). And also, PP4 regulates anti-cohesin pathway through interaction with Wpl1, cohesin and WAPL (35, 36). Furthermore, Pph3, concerted with but independent to Slx4, is required for termination of replicative stress signaling (37) and regulates checkpoint signaling by interaction with Mec1 (ATR yeast homolog) (38). Besides, knockdown of PP4C and PP4R2 increases the phosphorylation of BAF (barrier-to-autointegration factor) at Ser-4 site, which is important for normal nuclear envelop formation and cell cycle progression (39). However, overexpression of PP4, as well as the absence of PP4, also impairs proper cell cycle progression, but each condition results in different phenotypes; prometaphase arrest and interphase arrest, respectively (40). In prometaphase/metaphase transition, the interplay between PP4 and SAF-A (scaffold attachment factor A) is necessary (40).

Most studies for cell cycle regulation-related PP4 functions have focused on the mitosis and meiosis events. However, considering that PP4 is required for recovery from a checkpoint-induced arrest by dephosphorylating and inactivating p53 in G1 phase (41), it is feasible that PP4 could have essential functions in other cell cycle phases.

DNA repair: To prevent detrimental accidents by DNA damage, eukaryotes have evolved highly conserved and refined mechanisms, known as DNA damage response (DDR). DNA double strand break (DSB) is one of the most hazardous type of DNA lesions, restored mainly by non-homologous end joining (NHEJ) or homologous recombination (HR). To progress proper DNA damage response, timely dephosphorylation is required for counteracting the phosphorylation by kinases and in fact, PP4 has indispensable roles in these sophisticated processes (3).

Phosphorylated form of histone H2AX, named as γ-H2AX, is induced upon DNA damage and thus, regarded as the DNA damage marker. Aberration of dephosphorylation of γ-H2AX by PP4 on time clearly impairs proper DDR and causes genomic instability (9, 42). PP4 also dephosphorylates RPA2, whose phosphorylation status is essential for DNA synthesis after DNA damage, G2/M phase checkpoint, and HR (5). Also, phosphorylation of 53BP1, one of most critical proteins in genomic stability and tumorigenesis, is mainly regulated by PP4 (8). 53BP1 must be highly phosphorylated at T1609/S1618 during mitosis so as not to be activated and thus, block error-prone NHEJ repair. However, PP4-mediated dephosphorylation of 53BP1 promotes the recruitment of 53BP1 to the DNA double strand break sites at the onset of G1 phase to secure genomic stability, but not in mitosis (8). When phospho-null mutants of 53BP1 (T1609A/S1618A) are recruited to DNA lesions in mitosis, chromosome segregation is largely impaired. Besides, DNA damage sites should be accessible to facilitate recruitment of DNA repair factors. When DNA lesions are generated, KAP-1, a transcriptional corepressor, is rapidly phosphorylated by ATM kinase, inducing relaxation of DNA lesions and thus promoting transcription of stress-induced genes, such as p21 and Gadd45α (growth arrest and DNA damage-inducible alpha) to initiate DNA repair in heterochromatin. Right after DNA repair is completed, PP4 induces KAP-1 dephosphorylation to recover its corepressive function (6). PP4 is also involved in NHEJ pathway, possibly through altering KAP-1 phosphorylation (43). According to phosphoproteomic analysis (6), PP4 could participate in other DNA repair pathways, such as DNA mismatch repair and base excision repair in addition to DNA DSB repairs, implying that PP4 could be universal regulator for DNA repair.

Considering the critical roles of PP4 as a phosphatase, PP4 should be tightly regulated for efficient DDR. In fact, the post-translational modifications of PP4C and its regulatory subunits have significant impact on PP4 activity. PP4C methylation on C-terminal leucine site (Leu307) by LCMT-1 (leucine carboxyl methyltransferase 1) is required for stable PP4 complex, enzymatic activity to its targets, such as KAP-1 and 53BP1, and thus, DNA DSB repairs (HR and NHEJ) (44, 45). Also, PP4 regulatory subunits, like PP4R2, PP4R3α, and PP4R3β, are phosphorylated to be inactivated in mitosis (30, 46). In particular, PP4R3β phosphorylation is required for maintaining 53BP1 phosphorylation and blocking premature 53BP1 foci formation in mitosis (45).

Recently, some endogenous PP4 inhibitors, such as DHX38 (DEAH box polypeptide 38), TIPRL (Tip41-like protein), and PP4IP (protein phosphatase 4 inhibitory protein), have been reported (47-49). DHX38 specifically interacts with PP4C in constitutive and damage-independent manner, and inhibits PP4 activity in vitro and in vivo, thus impacting DNA DSB repairs, and DNA synthesis after damage (47). PP4IP also interacts with PP4, but its inhibitory function depends on DNA damage and cell cycle, especially mitosis. PP4IP knockout promotes the stability of PP4C-PP4R2-PP4R3α complex, but overexpression and depletion of PP4IP impair DNA DSB repairs and cell survival, suggesting that timely regulation of PP4 is essential for DNA repair and cell survival (49). And TIPRL downregulates PP4 activity by inhibiting the interaction between PP4C and PP4R2 by interception of PP4C from PP4C-PP4R2 complex (48). The fact that no synthetic inhibitor has been discovered makes it attractive to study the development of specific inhibitor to PP4. The PP4-specific inhibitor that has no impact on other phosphatases will be applied as beneficial material for treating PP4-overexpressing cancers and investigating PP4 functions in more detail.

Similar to mammalian cells, PP4 is also regarded as an essential element in yeast DDR. PPH3 prevents hyperphosphorylation of Rad53 (checkpoint kinase 2, CHK2, yeast homolog), thus affecting DNA end resection at DSBs (14), and also promotes telomere healing at accidental breaks by opposing Cdc13 phosphorylation, even though it is unknown whether PPH3 directly dephosphorylates Cdc13 (50). Besides, PPH3 depletion alleviates DNA damage accumulation and rescues the short lifespan in maf1D cells (51). Maf1, a repressor of RNA polymerase III transcription, was reported to be dephosphorylated by PPH3 during unfavorable conditions, such as nutrient deprivation (52).

Not always, but in many cases, protein functions in yeast homolog are reflected in the human system. Thus, it is quite convincing that human PP4 regulates CHK2-mediated activity and telomere-related events. Actually, the phosphorylation of KAP-1 by CHK2 is regulated by PP4 and hyperphosphorylation of 53BP1 in mitosis induced by PP4 inactivation prevents telomere fusion (6, 53).

Immunity

Immune cell development and activation are regulated by extremely sophisticated pathways, and dysfunction of these processes leads to many hazardous immune disorders. To prevent such catastrophic incidents, PP4 participates in various immune-related processes, such as immune cell lineage development, cytokine secretion, and immune cell receptor signaling.

Pp4 gene knockout in the T-cell lineage causes aberrant thymocyte development, including T cell arrest at the double-negative 3 stage (CD4⁻CD8⁻CD25^＋CD44⁻), abnormal thymocyte maturation, and lower efficacy of positive selection with impaired PLCγ1 (phospholipase C-γ1)-ERK (extracellular signal-regulated kinase) activation (54). Also, PP4 deficiency induces partial αβ T lymphopenia and T cell hypo-proliferation, as well as significant reductions in the numbers of thymic and peripheral Treg cells (regulatory T cells), thus inducing defective adaptive immunity (55). These aberrations are associated with decreased IL-10, CTLA-4 (cytotoxic T-lymphocyte-associated protein 4), GITR (glucocorticoid-induced TNFR-related protein), and CD103 expression, elevated transcriptional expression of CDK inhibitors including p15, p16, and p21, and enhanced AMPK (AMP kinase) activation (55, 56). Also, mice with T cell-specific ablation of the pp4c gene develop spontaneous rectal prolapse and colitis with symptom similar to human Crohn’s disease (55). Besides, PP4 is related to signaling pathways in T cells. HPK1 (hematopoietic progenitor kinase 1), a member of mammalian Ste20-like protein kinases, has been implicated in many cellular signaling pathways including TCR and BCR (T cell and B cell receptor, respectively) signaling. TCR stimulation promotes the interaction between PP4 and HPK1, and PP4 induces TCR-mediated activation of HPK1 in Jurkat T cells (57). Also, the activation of JNK and p38, but not ERKs, is a target for the PP4 in the Jurkat cell line (58).

PP4 is equally essential for B-cell lineage development. Ablation of PP4 in B-cell lineage leads to reduction in pre-B cell numbers, an absence in immature B cells, and a complete loss of mature B cells (59). In the PP4-knockout B cells, immunoglobulin (Ig) class switch recombination is impaired and the basal levels of serum immunoglobulins of all isotypes are reduced (59-61). However, beyond the cell proliferation phase, the conditional deletion of PP4 completely restores normal IgG1 production in B cells of immunized mice (61). The pp4 gene-ablated mice fail to form germinal centers in the spleen and the draining mediastinal lymph nodes, and do not efficiently mount antigen-specific humoral response, associated with lower activation of ERK and JNK, and IκBα (inhibitor of κB α) degradation, both of which are mediated by CD40 (60).

In addition to roles in T and B cells, PP4 is an essential component in other immune cells including macrophage. Type I IFN production is indispensable for antiviral innate immune response, and TBK1 (TANK-binding kinase 1) plays crucial roles in type I IFN production. PP4 suppresses production of type I IFN and IFN-stimulated genes by dephosphorylating and inhibiting TBK1 (62).

Similar to the conflicting role in genomic stability, the overexpression and depletion of PP4 cause apoptosis in T cells, meaning that PP4 can be proapoptotic or antiapoptotic gene (54, 63, 64). Interestingly, the knockout of PP4 in rodents causes embryonic lethality (54), suggesting that tight regulation or adequate expression of PP4 is pivotal in immune system development, at least in T cell lineage.

Glucose homeostasis

The dysfunction of glucose homeostasis leads to critical metabolic disorders, such as diabetes and obesity. Insulin resistance is one of the main causes contributing to impaired glucose dysregulation (65). Recently, accumulating data indicate that PP4 is related to insulin resistance and glucose metabolism.

In type 2 diabetic db/db mice or insulin-resistant mice treated with TNF-α (tumor necrosis factor α), the expression of PP4C and PP4R1 in protein level and PP4R3α/β in mRNA level is increased, and downregulation of PP4 alleviates the insulin resistance (66-69), though the alteration of PP4R2 expression level remains elusive. It was reported that TNF-α induces the phosphorylation and activation of PP4C, subsequently leading to the activation of JNK (70). However, it seems that PP4 may regulate JNK function in an indirect manner, since PP4 does not physically interact with JNK (70). Also, upon the activation of JNK, the interaction of IRS-1 (insulin receptor substrate 1) with PP4 causes the decreased expression of IRS-1 and increased phosphorylation of IRS-1 (68). Additionally, TNF-α downregulates IRS-4 expression, which depends on the phosphatase activity of PP4. But, it is unknown whether PP4 dephosphorylates IRS-4 directly (71).

ACC1 (acetyl-CoA carboxylase 1) is associated with hepatic lipogenesis, and its phosphorylation by AMPK blocks lipid synthesis and is reversed by PP4 (66). Consistently, PP4 dephosphorylates AMPK in Ca^2＋ dependent manner, thus blocking lipid consumption (72). Furthermore, PP4 is involved in gluconeogenesis. Overexpression of PP4R3α/β induces dephosphorylation of CRTC2 (cAMP-response element binding protein-regulated transcriptional coactivator 2) and promotes transcription of gluconeogenesis-related genes (69). It remains to be seen whether PP4 directly dephosphorylates CRTC2. Also, as another role in glucose signaling, PPH3 and PSY2 (PP4C and PP4R3 yeast homolog, respectively) dephosphorylate Mth1 (MutT homolog 1) in glucose withdrawal condition, causing the binding of Rgt1 (restores glucose transport protein 1) to the promoters of glucose transporter (HXT) genes and represses their expression (73).

Neuronal development

SMA (Spinal muscular atrophy) is an autosomal recessive neurodegenerative disease characterized by progressive loss of motor neurons from the anterior horn of the spinal cord, resulting in paralysis and severe muscular atrophy (74). SMA mainly arises from deletions or mutations in SMN1 (Survival of Motor Neuron 1) gene and its abnormal high expression. SMN complexes participate in spliceosome assembly and regeneration of spliceosomal components. PP4R2 interacts with Gemin3 and Gemin4, identified as components of the SMN protein complex. Also, PP4R2 promotes the temporal localization of newly formed snRNPs and modulates the differentiation and survival of neuronal cells (74, 75).

Hedgehog signaling is related to the development in vertebrates and invertebrates, and Smo (the seven-transmembrane protein smoothened) is an essential factor in Hedgehog signaling (76). In Drosophila, PP4 dephosphorylates Smo and alleviates its signaling activity (77). Wnt signaling regulates growth and proliferation, cell-fate differentiation, stem cell renewal and homeostasis (78). In embryonic stem cells, PP4R3α/β suppresses the transcription of Wnt target gene brachyury through recruitment of HDAC1 (histone deacetylase 1) to its promoter to maintain pluripotency (79). However, in Drosophila development, PP4 promotes the Notch signaling to induce expression of wg (wingless), and Ryk (Receptor-like tyrosine kinase; a Wnt receptor) intracellular domain, in complex with PP4R3α/β that regulates the gene transcription for neuronal differentiation (78, 80). Additionally, PP4 promotes the axonal regeneration after only peripheral injury, but not spinal cord injury, by dephosphorylating and inactivating HDAC3 (81). Similarly, HDAC3 activity is inhibited by PP4C/PP4R1 complex in HeLa cell, a cervical cancer cell line (82). Also, PP4R3α/β induces Mbd3 (methyl-CpG-binding domain 3) degradation and blocks recruitment of the repressive Mbd3/NuRD (nucleosome remodeling and deacetylase) complex to the neurogenesis-related gene loci (83). Interestingly, the clearance of severed or degenerating axons also requires PP4 in drosophila, bridging the glial receptor Draper to cytoskeletal remodeling through the SOS GEF (guanine nucleotide exchange factor) complex and the GTPase Rac1 to ensure glial infiltration of injury sites and clearance of degenerating neuronal materials (84).

Drosophila NBs (neuroblasts), stem cell-like neural progenitors, undergo repeated asymmetric divisions to self-renew and generate neurons and/or glia. During each round of division, the cell fate determinants, such as Pros (Prospero) and Brat (Brain Tumor), are asymmetrically localized and preferentially segregated into the GMCs (ganglion mother cells). Asymmetric localization of Pros and Brat is mediated through direct interactions with Mira (Miranda) (85). Pp4-19C or PPP4R2r (PP4C or PP4R2 Drosophila homologs) facilitate localization of Mira and PP4R3/Flfl interacts directly with Mira (85, 86). Also, PP4 complex associates with PTPA (phosphotyrosyl phosphatase activator), thus inducing dephosphorylation of Mira and directing cortical localization of Mira (86). In developing mammalian brains, neural progenitors expand by symmetric division before switching to an asymmetric division mode to generate neurons (87). PP4 facilitates mitotic spindles orientation in parallel to the neuroepithelial surface through NDEL1 dephosphorylation, thus preventing premature neurogenesis (88). Conversely, it was reported that PP4/PP4R3α complex promotes neuronal differentiation and suppresses the proliferative capacity of neural progenitor cells by suppressing Par3, a negative regulator of neuronal differentiation (89).

Plant and others

PP4 functions also have been elucidated in other various biological fields, though requiring more information in future. First, Arabidopsis thaliana as a model organism in plant biology has two PP4 catalytic subunit genes, PPX1 and PPX2. PP4R3A, with these catalytic subunits, assembles a functional PP4 complex to target Hyponastic Leaves 1, HYL1 (90). HYL1 has a role in promoting miRNA biogenesis, antagonized and degraded by the MAPK pathway. PP4 complexes stabilize and also dephosphorylate HYL1 to promote miRNA biogenesis, inhibiting MAPK signal cascade. Also, PP4R3A interacts with RNA polymerase II and recruits it to the promoters of miRNA-encoding (MIR) genes (91). Additionally, it was shown that PP4R3A gene is related to plant growth, root morphology, and genomic integrity in Arabidopsis thaliana (92).

PP4 can activate or inhibit NF-κB signaling. Signaling to NF-κB is crucial for T cell activation, differentiation, and proliferation as it regulates a wide variety of target genes such as different cytokines (e.g., IL-2, IFN-γ, and TNF-α), chemokines (e.g., IL-8), and anti-apoptotic molecules (e.g., Bcl-2 and c-IAPs; cellular inhibitor of apoptosis protein 1) (93). PP4C-PP4R1 complex functions as the negative regulator between IκB and IKK (IκB kinase) complex. Inactivation of IKK by PP4C/PP4R1-mediated dephosphorylation keeps IκB dephosphorylated and thereby, prevents the activation of NF-κB (93). PP4 also negatively regulates LPS-induced and TRAF6 (TNF receptor-associated factor 6)-mediated NF-κB activation by inhibiting the ubiquitination of TRAF6 (94). Although PP4 physically interacts with TRAF6 and is recruited to TLR4 (toll-like receptor 4) complex upon LPS (lipopolysaccharide) stimulation, whether PP4 regulates TRAF6 by direct dephosphorylation remains to be elucidated.

In non-immune cells, PP4 stimulates c-Rel-mediated DNA binding and NF-κB-mediated transcription, and decreases threonine phosphorylation on p65 subunit of NF-κB for its activation (95, 96). Conversely, PP4 can also inactivate NF-κB activity by dephosphorylation of TRAF2, inhibition of TRAF6 polyubiquitination, and interaction with tAg (small T antigen) of MCPyV (merkel cell polyomavirus) and NEMO (NF-κB essential modulator) adaptor protein (97, 98).

In Neurospora, PP4 dephosphorylates and activates WHITE COLLAR complex (WCC), phosphorylated by FREQUENCY-mediated manner to close circadian negative feedback loop (99). Additionally, PP4 inhibits thiazide-sensitive Na^＋-Cl⁻ cotransporter (NCC) in Xenopus oocytes, but it is unknown that PP4 directly dephosphorylates NCC, although its phosphatase activity is required for NCC inhibition (100). Furthermore, PP4 is expressed in the distal convoluted tubule of mouse kidney (100). These data suggest the possible role of PP4 in the regulation of the electrolyte transporter.

Emerging evidence clearly suggests that PP4 plays multifaceted roles which control a variety of cellular phenomena. In the light of the significant impact of PP4 in cells, it is obvious that a more intensive study should be pursued to achieve better understanding of the working mechanisms in organism, as well as to clarify conflicting results observed in the different experimental systems. In that scenario, PP4 could be harnessed for the development of therapeutic materials. For example, since PP4C is considered an oncoprotein frequently overexpressed or irrelevantly regulated in a number of tumor types, discovering molecules as an inhibitor suppressing or blocking the gene expression or inhibiting directly enzymatic functions of PP4 is sufficiently persuasive and promising. From another perspective, the synthetic inhibitor, specific to PP4C, can be developed applying an entire or functional region of endogenous protein inhibitors identified. Inhibitors has been used in the studies on PP4 also inhibits other phosphatases meaning that there is no PP4-specific inhibitor developed. The PP4 inhibitor to be produced should be valuable for investigating PP4-specific functions and targeting tumors particularly with the high level of PP4C expression in the long term.

This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning (grant number: NRF-2017R1A2B4007852).

The authors have no conflicting interests.